USP's focus in 2013 involves standards relating to organic impurities, measurement of residual DNA and host-cell proteins in biotechnology products, and elemental impurities.
Kahkashan Zaidi, PhD
Advertisement
Kahkashan Zaidi, PhD,* is a senior scientist in the Department of Standards Development; at the US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790, tel. 301.816.8269, kxz@usp.org
Articles by Kahkashan Zaidi, PhD
USP monographs, if they are consistently observed and applied, can help reduce medical gas errors.
Advertisement
Latest Updated Articles
- Standards-Setting Activities on Impurities
Published: January 2nd 2013 | Updated:
- USP Initiatives for the Safe Use of Medical Gases
Published: November 2nd 2005 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
